Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
3-year results show that patients who underwent low-risk aortic valve replacement continue to report lower rates of all-cause mortality and stroke with TAVI compared to surgery
Read Full NewsThe expanded indication brings n-butyl cyanoacrylate’s established performance into the treatment of chronic subdural hematoma, a condition for which traditional surgical interventions may not always be suitable or effective.
Impacts of the Lancet Commission on Obesity Treatment, With Pooja Singhal, MD
1.
Study finds that AI is better at forecasting the risk of developing cancer.
2.
When it comes to LBCL relapse in complete remission, ASCT outperforms CAR T-cell therapy.
3.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
4.
ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer
5.
Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards
1.
Decoding Hamartomas: Understanding Their Causes and Symptoms
2.
Beyond the Blood: Expanding CAR T-Cell Therapy to Solid Tumors- A New Era of Precision Oncology
3.
First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care
4.
AI in Genomics: Decoding the Human Genome for Cancer Treatment
5.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
2.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
5.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge